713 related articles for article (PubMed ID: 31441355)
1. Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.
Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Asada T; Fujiwara A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Nishimura K; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
J Am Heart Assoc; 2019 Sep; 8(17):e011468. PubMed ID: 31441355
[TBL] [Abstract][Full Text] [Related]
2. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
4. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
[TBL] [Abstract][Full Text] [Related]
5. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
[TBL] [Abstract][Full Text] [Related]
6. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
7. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
deFilippi CR; Seliger SL; Maynard S; Christenson RH
Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
[TBL] [Abstract][Full Text] [Related]
8. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
9. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
Takase H; Dohi Y
Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.
Fadini GP; Bonora BM; Albiero M; Zaninotto M; Plebani M; Avogaro A
Cardiovasc Diabetol; 2017 Feb; 16(1):22. PubMed ID: 28183314
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.
Jafri L; Kashif W; Tai J; Siddiqui I; Azam I; Shahzad H; Ghani F
BMC Nephrol; 2013 May; 14():117. PubMed ID: 23725445
[TBL] [Abstract][Full Text] [Related]
12. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure.
Wettersten N; Horiuchi Y; van Veldhuisen DJ; Mueller C; Filippatos G; Nowak R; Hogan C; Kontos MC; Cannon CM; Müeller GA; Birkhahn R; Taub P; Vilke GM; Barnett O; McDonald K; Mahon N; Nuñez J; Briguori C; Passino C; Murray PT; Maisel A
Eur J Heart Fail; 2019 Dec; 21(12):1553-1560. PubMed ID: 31769140
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.
Noveanu M; Breidthardt T; Potocki M; Reichlin T; Twerenbold R; Uthoff H; Socrates T; Arenja N; Reiter M; Meissner J; Heinisch C; Stalder S; Mueller C
Crit Care; 2011; 15(1):R1. PubMed ID: 21208408
[TBL] [Abstract][Full Text] [Related]
16. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
[TBL] [Abstract][Full Text] [Related]
17. Molecular ratio of mature B-type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery.
Kimura A; Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Nakagawa Y; Yasuda S; Anzai T; Minamino N; Izumi C
ESC Heart Fail; 2021 Dec; 8(6):5617-5621. PubMed ID: 34726346
[TBL] [Abstract][Full Text] [Related]
18. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
